PT  - JOURNAL ARTICLE
AU  - Shahjouei, Shima
AU  - Tsivgoulis, Georgios
AU  - Farahmand, Ghasem
AU  - Koza, Eric
AU  - Mowla, Ashkan
AU  - Sadr, Alireza Vafaei
AU  - Kia, Arash
AU  - Far, Alaleh Vaghefi
AU  - Mondello, Stefania
AU  - Cernigliaro, Achille
AU  - Ranta, Annemarei
AU  - Punter, Martin
AU  - Khodadadi, Faezeh
AU  - Sabra, Mirna
AU  - Ramezani, Mahtab
AU  - Naderi, Soheil
AU  - Olulana, Oluwaseyi
AU  - Chaudhary, Durgesh
AU  - Lyoubi, Aicha
AU  - Campbell, Bruce
AU  - Arenillas, Juan F.
AU  - Bock, Daniel
AU  - Montaner, Joan
AU  - Neshin, Saeideh Aghayari Sheikh
AU  - de Sousa, Diana Aguiar
AU  - Tenser, Matthew S.
AU  - Aires, Ana
AU  - Alfonso, Merccedes De Lera
AU  - Alizada, Orkhan
AU  - Azevedo, Elsa
AU  - Goyal, Nitin
AU  - Babaeepour, Zabihollah
AU  - Banihashemi, Gelareh
AU  - Bonati, Leo H.
AU  - Cereda, Carlo
AU  - Chang, Jason J.
AU  - Crnjakovic, Miljenko
AU  - De Marchis, GianMarco
AU  - Del Sette, Massimo
AU  - Ebrahimzadeh, Seyed Amir
AU  - Farhoudi, Mehdi
AU  - Gandoglia, Ilaria
AU  - Gonçalves, Bruno
AU  - Griessenauer, Christoph
AU  - Hancı, Mehmet Murat
AU  - Katsanos, Aristeidis H.
AU  - Krogias, Christos
AU  - Leker, Ronen
AU  - Lotman, Lev
AU  - Mai, Jeffrey
AU  - Male, Shailesh
AU  - Malhotra, Konark
AU  - Malojcic, Branko
AU  - Mesquita, Teresa
AU  - Mirghasemi, Asadollah
AU  - Aref, Hany Mohamed
AU  - Afshar, Zeinab Mohseni
AU  - Moon, Jusun
AU  - Niemelä, Mika
AU  - Jahromi, Behnam Rezaei
AU  - Nolan, Lawrence
AU  - Pandhi, Abhi
AU  - Park, Jong-Ho
AU  - Marto, João Pedro
AU  - Purroy, Francisco
AU  - Ranji-Burachaloo, Sakineh
AU  - Carreira, Nuno Reis
AU  - Requena, Manuel
AU  - Rubiera, Marta
AU  - Sajedi, Seyed Aidin
AU  - Sargento-Freitas, João
AU  - Sharma, Vijay
AU  - Steiner, Thorsten
AU  - Tempro, Kristi
AU  - Turc, Guillaume
AU  - Ahmadzadeh, Yassaman
AU  - Almasi-Dooghaee, Mostafa
AU  - Assarzadegan, Farhad
AU  - Babazadeh, Arefeh
AU  - Baharvahdat, Humain
AU  - Cardoso, Fabricio
AU  - Dev, Apoorva
AU  - Ghorbani, Mohammad
AU  - Hamidi, Ava
AU  - Hasheminejad, Zeynab Sadat
AU  - Komachali, Sahar Hojjat-Anasri
AU  - Khorvash, Fariborz
AU  - Kobeissy, Firas
AU  - Mirkarimi, Hamidreza
AU  - Mohammadi-Vosough, Elahe
AU  - Misra, Debdipto
AU  - Noorian, Ali Reza
AU  - Nowrouzi-Sohrabi, Peyman
AU  - Paybast, Sepideh
AU  - Poorsaadat, Leila
AU  - Roozbeh, Mehrdad
AU  - Sabayan, Behnam
AU  - Salehizadeh, Saeideh
AU  - Saberi, Alia
AU  - Sepehrnia, Mercedeh
AU  - Vahabizad, Fahimeh
AU  - Yasuda, Thomas
AU  - Marvast, Ahmadreza Hojati
AU  - Ghabaee, Mojdeh
AU  - Rahimian, Nasrin
AU  - Harirchian, Mohammad Hossein
AU  - Borhani-Haghighi, Afshin
AU  - Arora, Rohan
AU  - Ansari, Saeed
AU  - Avula, Venkatesh
AU  - Li, Jiang
AU  - Abedi, Vida
AU  - Zand, Ramin
TI  - SARS-CoV-2 and Stroke Characteristics: A Report from the Multinational COVID-19 Stroke Study Group
AID  - 10.1101/2020.08.05.20169169
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.05.20169169
4099  - http://medrxiv.org/content/early/2020/08/12/2020.08.05.20169169.short
4100  - http://medrxiv.org/content/early/2020/08/12/2020.08.05.20169169.full
AB  - Background Stroke is reported as a consequence of SARS-CoV-2 infection. However, there is a lack of regarding comprehensive stroke phenotype and characteristicsMethods We conducted a multinational observational study on features of consecutive acute ischemic stroke (AIS), intracranial hemorrhage (ICH), and cerebral venous or sinus thrombosis (CVST) among SARS-CoV-2 infected patients. We further investigated the association of demographics, clinical data, geographical regions, and countries’ health expenditure among AIS patients with the risk of large vessel occlusion (LVO), stroke severity as measured by National Institute of Health stroke scale (NIHSS), and stroke subtype as measured by the TOAST criteria. Additionally, we applied unsupervised machine learning algorithms to uncover possible similarities among stroke patients.Results Among the 136 tertiary centers of 32 countries who participated in this study, 71 centers from 17 countries had at least one eligible stroke patient. Out of 432 patients included, 323(74.8%) had AIS, 91(21.1%) ICH, and 18(4.2%) CVST. Among 23 patients with subarachnoid hemorrhage, 16(69.5%) had no evidence of aneurysm. A total of 183(42.4%) patients were women, 104(24.1%) patients were younger than 55 years, and 105(24.4%) patients had no identifiable vascular risk factors. Among 380 patients who had known interval onset of the SARS-CoV-2 and stroke, 144(37.8%) presented to the hospital with chief complaints of stroke-related symptoms, with asymptomatic or undiagnosed SARS-CoV-2 infection. Among AIS patients 44.5% had LVO; 10% had small artery occlusion according to the TOAST criteria. We observed a lower median NIHSS (8[3-17], versus 11 [5-17]; p=0.02) and higher rate of mechanical thrombectomy (12.4% versus 2%; p<0.001) in countries with middle to high-health expenditure when compared to countries with lower health expenditure. The unsupervised machine learning identified 4 subgroups, with a relatively large group with no or limited comorbidities.Conclusions We observed a relatively high number of young, and asymptomatic SARS-CoV-2 infections among stroke patients. Traditional vascular risk factors were absent among a relatively large cohort of patients. Among hospitalized patients, the stroke severity was lower and rate of mechanical thrombectomy was higher among countries with middle to high-health expenditure.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was designed by the investigators at the Neuroscience Institute of Geisinger Health System, Pennsylvania, USA, and received approval by the Institutional Review Board of Geisinger Health System and other participating institutions.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable upon request